Evotec
Evotec
Global life science company pioneering drug discovery and development through AI-driven innovation and advanced technologies.
About
Evotec is a global life science company focused on comprehensive drug discovery and development services. They integrate breakthrough science with AI-driven innovation and advanced technologies to accelerate the journey from concept to cure. Their expertise spans small molecules, biologics, and cell therapies, supported by proprietary platforms and flexible partnering models.
Key facts
- Website
- evotec.com
- Type
- Corporate VC
- Headquarters
- Hamburg, Germany
- Funds raised
- $150M
- Portfolio companies
- 4
- Stages
- Series APre-SeedSeedSeries BSeries C
- Cheque size
- $30M to $60M
- Sector focus
- BiotechnologyHealthcarePharmaceuticalLife ScienceDrug Discovery
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 15 Jun 2026 | Cellares | Funding Round | $50M |
| 9 Jun 2026 | Cellares | Series D | $277M |
| 24 Feb 2026 | Centauri Therapeutics | Series A | $8M |
| 16 Oct 2025 | Tubulis | Series C | $333M |
| 29 Jul 2025 | Centauri Therapeutics | Grant | $5M |
| 26 Nov 2024 | Centauri Therapeutics | Grant | $1M |
| 24 Feb 2024 | Centauri Therapeutics | Series A | $8M |
| 10 May 2023 | Tubulis | Undisclosed round | $60M |
| 16 Feb 2022 | Centauri Therapeutics | Series A | $30M |
| 27 Apr 2021 | Tubulis | Undisclosed round | $30M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has Evotec invested in?
Evotec has invested in Cellares, Centauri Therapeutics, Tubulis, Biomica.
SEC filings, insider activity, nonprofit links and pay benchmarks for Evotec:
